{
  "name": "Episurf Medical AB",
  "slug": "episurf-medical-ab",
  "description": "Statiskt källarkiv med kurshistorik, finansiella rapporter och regulatoriska dokument. För nordiska bolag används Nasdaq Nordic primärt och MFN endast för saknade rapportperioder.",
  "status": "complete",
  "updated_at": "2026-08-07T03:19:48Z",
  "nasdaq_status": "retrieved",
  "latest_market": "2026-08-06: stängning 0.0607, volym 6025123",
  "mfn_status": "resolved_no_reports",
  "mfn_count": 0,
  "nasdaq_reports_status": "retrieved",
  "reports": {
    "available": true,
    "url": "/company/episurf-medical-ab/reports",
    "count": 16,
    "nasdaq_count": 16,
    "mfn_fallback_count": 0,
    "items": [
      {
        "report_key": "2026:q1",
        "period_label": "2026 Q1",
        "date": "2026-05-25",
        "title": "Kvartalsrapport Q1 2026",
        "original_title": "Rättelse: Saknad MAR-etikett i tidigare pressmeddelande - Delårsrapport 1 januari - 31 mars 2026",
        "category": "Interimsrapport",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://view.news.eu.nasdaq.com/view?id=b0fd2aeec5fb7a9565febc2bcf1d51c52&lang=sv&src=listed",
        "language": "sv",
        "report_type": "interim-report",
        "fiscal_year": 2026,
        "quarter": "q1",
        "documents": [
          {
            "doc_id": "nasdaq-nordic-kvartalsrapport-q1-2026",
            "title": "Kvartalsrapport Q1 2026",
            "source": "Nasdaq Nordic",
            "source_class": "nasdaq-report",
            "source_url": "https://attachment.news.eu.nasdaq.com/aab8a43e74fee5eace7bce8c45a8620f8",
            "date": "2026-05-25",
            "period": "2026-q1",
            "form_type": "interim-report",
            "report_key": "2026:q1",
            "filename": "05256593.pdf",
            "text_chars": 33267,
            "sha256": "5d82cf9d28de6d24fe2cafdcf299b47e6f69cf52c5ded7e4ce7ab0083547a295",
            "url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2026",
            "absolute_url": "https://spela.port0.org/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2026",
            "txt_url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2026/fulltext.txt",
            "absolute_txt_url": "https://spela.port0.org/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2026/fulltext.txt",
            "parts": [
              {
                "number": 1,
                "url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2026/part-001.html",
                "chars": 33267
              }
            ]
          }
        ],
        "alternatives": []
      },
      {
        "report_key": "2025:annual",
        "period_label": "2025 Årsredovisning",
        "date": "2026-03-20",
        "title": "Årsredovisning 2025",
        "original_title": "Episurf Medical AB publicerar årsredovisning för 2025",
        "category": "Bokslut och Verksamhetsberättelse",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://view.news.eu.nasdaq.com/view?id=b8f2373a3f89a4541b72925e8667191c5&lang=sv&src=listed",
        "language": "sv",
        "report_type": "annual-report",
        "fiscal_year": 2025,
        "quarter": "annual",
        "documents": [
          {
            "doc_id": "nasdaq-nordic-arsredovisning-2025",
            "title": "Årsredovisning 2025",
            "source": "Nasdaq Nordic",
            "source_class": "nasdaq-report",
            "source_url": "https://attachment.news.eu.nasdaq.com/a81b93c940a2b2561fb907e5d4868092e",
            "date": "2026-03-20",
            "period": "2025-annual",
            "form_type": "annual-report",
            "report_key": "2025:annual",
            "filename": "03207922.pdf",
            "text_chars": 284791,
            "sha256": "98f52adea34923f38cbece510aa866da6c82126f0c580e5291cbb9abdb60f0f5",
            "url": "/company/episurf-medical-ab/documents/nasdaq-nordic-arsredovisning-2025",
            "absolute_url": "https://spela.port0.org/company/episurf-medical-ab/documents/nasdaq-nordic-arsredovisning-2025",
            "txt_url": "/company/episurf-medical-ab/documents/nasdaq-nordic-arsredovisning-2025/fulltext.txt",
            "absolute_txt_url": "https://spela.port0.org/company/episurf-medical-ab/documents/nasdaq-nordic-arsredovisning-2025/fulltext.txt",
            "parts": [
              {
                "number": 1,
                "url": "/company/episurf-medical-ab/documents/nasdaq-nordic-arsredovisning-2025/part-001.html",
                "chars": 179732
              },
              {
                "number": 2,
                "url": "/company/episurf-medical-ab/documents/nasdaq-nordic-arsredovisning-2025/part-002.html",
                "chars": 105057
              }
            ]
          }
        ],
        "alternatives": []
      },
      {
        "report_key": "2025:q4",
        "period_label": "2025 Q4",
        "date": "2026-02-06",
        "title": "Kvartalsrapport Q4 2025",
        "original_title": "BOKSLUTSKOMMUNIKÉ 1 JANUARI - 31 DECEMBER 2025",
        "category": "Bokslutskommuniké",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://view.news.eu.nasdaq.com/view?id=bebe861794b68c63db7648158939fc184&lang=sv&src=listed",
        "language": "sv",
        "report_type": "year-end-report",
        "fiscal_year": 2025,
        "quarter": "q4",
        "documents": [
          {
            "doc_id": "nasdaq-nordic-kvartalsrapport-q4-2025",
            "title": "Kvartalsrapport Q4 2025",
            "source": "Nasdaq Nordic",
            "source_class": "nasdaq-report",
            "source_url": "https://attachment.news.eu.nasdaq.com/a1bb32b8b6f7e30d498619f54e258bf24",
            "date": "2026-02-06",
            "period": "2025-q4",
            "form_type": "year-end-report",
            "report_key": "2025:q4",
            "filename": "02045726.pdf",
            "text_chars": 43151,
            "sha256": "c388d1c855910f4f5c9ba52e62b0685e49760c8f452685d125a74a427e4870b5",
            "url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q4-2025",
            "absolute_url": "https://spela.port0.org/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q4-2025",
            "txt_url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q4-2025/fulltext.txt",
            "absolute_txt_url": "https://spela.port0.org/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q4-2025/fulltext.txt",
            "parts": [
              {
                "number": 1,
                "url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q4-2025/part-001.html",
                "chars": 43151
              }
            ]
          }
        ],
        "alternatives": []
      },
      {
        "report_key": "2025:q3",
        "period_label": "2025 Q3",
        "date": "2025-10-24",
        "title": "Kvartalsrapport Q3 2025",
        "original_title": "Delårsrapport 1 januari - 30 september 2025",
        "category": "Interimsrapport",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://view.news.eu.nasdaq.com/view?id=b19340b196898e8d63427c8bfb089dcf3&lang=sv&src=listed",
        "language": "sv",
        "report_type": "interim-report",
        "fiscal_year": 2025,
        "quarter": "q3",
        "documents": [
          {
            "doc_id": "nasdaq-nordic-kvartalsrapport-q3-2025",
            "title": "Kvartalsrapport Q3 2025",
            "source": "Nasdaq Nordic",
            "source_class": "nasdaq-report",
            "source_url": "https://attachment.news.eu.nasdaq.com/a60352723909d02bdb354d97cd07a8fe0",
            "date": "2025-10-24",
            "period": "2025-q3",
            "form_type": "interim-report",
            "report_key": "2025:q3",
            "filename": "10238921.pdf",
            "text_chars": 46826,
            "sha256": "9b9ee7842ea7c3f79acd844498db660d1369325111fd9f9fc529dacb619a69bc",
            "url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q3-2025",
            "absolute_url": "https://spela.port0.org/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q3-2025",
            "txt_url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q3-2025/fulltext.txt",
            "absolute_txt_url": "https://spela.port0.org/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q3-2025/fulltext.txt",
            "parts": [
              {
                "number": 1,
                "url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q3-2025/part-001.html",
                "chars": 46826
              }
            ]
          }
        ],
        "alternatives": []
      },
      {
        "report_key": "2025:q2",
        "period_label": "2025 Q2",
        "date": "2025-07-11",
        "title": "Kvartalsrapport Q2 2025",
        "original_title": "Delårsrapport 1 januari - 30 juni 2025",
        "category": "Interimsrapport",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://view.news.eu.nasdaq.com/view?id=b3b6c3039e428f6bf2dffdea6c6e81996&lang=sv&src=listed",
        "language": "sv",
        "report_type": "interim-report",
        "fiscal_year": 2025,
        "quarter": "q2",
        "documents": [
          {
            "doc_id": "nasdaq-nordic-kvartalsrapport-q2-2025",
            "title": "Kvartalsrapport Q2 2025",
            "source": "Nasdaq Nordic",
            "source_class": "nasdaq-report",
            "source_url": "https://attachment.news.eu.nasdaq.com/a97b92923ca6221d0b7b355374cdf8c11",
            "date": "2025-07-11",
            "period": "2025-q2",
            "form_type": "interim-report",
            "report_key": "2025:q2",
            "filename": "07108252.pdf",
            "text_chars": 42301,
            "sha256": "fed67fa327fcc0fe2a3c219c8466c92a00c08a61a455f69b30fe40078b228b88",
            "url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2025",
            "absolute_url": "https://spela.port0.org/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2025",
            "txt_url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2025/fulltext.txt",
            "absolute_txt_url": "https://spela.port0.org/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2025/fulltext.txt",
            "parts": [
              {
                "number": 1,
                "url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2025/part-001.html",
                "chars": 42301
              }
            ]
          }
        ],
        "alternatives": []
      },
      {
        "report_key": "2025:q1",
        "period_label": "2025 Q1",
        "date": "2025-04-10",
        "title": "Kvartalsrapport Q1 2025",
        "original_title": "Delårsrapport 1 januari - 31 mars 2025",
        "category": "Interimsrapport",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://view.news.eu.nasdaq.com/view?id=bd069cb94f0918990aafbc4c3995f1bf4&lang=sv&src=listed",
        "language": "sv",
        "report_type": "interim-report",
        "fiscal_year": 2025,
        "quarter": "q1",
        "documents": [
          {
            "doc_id": "nasdaq-nordic-kvartalsrapport-q1-2025",
            "title": "Kvartalsrapport Q1 2025",
            "source": "Nasdaq Nordic",
            "source_class": "nasdaq-report",
            "source_url": "https://attachment.news.eu.nasdaq.com/aa09ea965d322c5501bb7401ee50c54b3",
            "date": "2025-04-10",
            "period": "2025-q1",
            "form_type": "interim-report",
            "report_key": "2025:q1",
            "filename": "04095665.pdf",
            "text_chars": 39392,
            "sha256": "1c826e86f766fb0916829100e81db6fc31b0edf779f85409a6d3e5c00a2bafd8",
            "url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2025",
            "absolute_url": "https://spela.port0.org/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2025",
            "txt_url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2025/fulltext.txt",
            "absolute_txt_url": "https://spela.port0.org/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2025/fulltext.txt",
            "parts": [
              {
                "number": 1,
                "url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2025/part-001.html",
                "chars": 39392
              }
            ]
          }
        ],
        "alternatives": []
      },
      {
        "report_key": "2024:annual",
        "period_label": "2024 Årsredovisning",
        "date": "2025-03-06",
        "title": "Årsredovisning 2024",
        "original_title": "Episurf Medical AB publicerar årsredovisning för 2024",
        "category": "Bokslut och Verksamhetsberättelse",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://view.news.eu.nasdaq.com/view?id=b48348410fe68557d1c9726cf5a4e2ba1&lang=sv&src=listed",
        "language": "sv",
        "report_type": "annual-report",
        "fiscal_year": 2024,
        "quarter": "annual",
        "documents": [
          {
            "doc_id": "nasdaq-nordic-arsredovisning-2024",
            "title": "Årsredovisning 2024",
            "source": "Nasdaq Nordic",
            "source_class": "nasdaq-report",
            "source_url": "https://attachment.news.eu.nasdaq.com/a8a25e81acbd157814da20927ed5b497e",
            "date": "2025-03-06",
            "period": "2024-annual",
            "form_type": "annual-report",
            "report_key": "2024:annual",
            "filename": "03067038.pdf",
            "text_chars": 284435,
            "sha256": "0d541124ef181df99beb4ec4704da40d9ab287a48f1aeb6b3a6a71caa17206f3",
            "url": "/company/episurf-medical-ab/documents/nasdaq-nordic-arsredovisning-2024",
            "absolute_url": "https://spela.port0.org/company/episurf-medical-ab/documents/nasdaq-nordic-arsredovisning-2024",
            "txt_url": "/company/episurf-medical-ab/documents/nasdaq-nordic-arsredovisning-2024/fulltext.txt",
            "absolute_txt_url": "https://spela.port0.org/company/episurf-medical-ab/documents/nasdaq-nordic-arsredovisning-2024/fulltext.txt",
            "parts": [
              {
                "number": 1,
                "url": "/company/episurf-medical-ab/documents/nasdaq-nordic-arsredovisning-2024/part-001.html",
                "chars": 178821
              },
              {
                "number": 2,
                "url": "/company/episurf-medical-ab/documents/nasdaq-nordic-arsredovisning-2024/part-002.html",
                "chars": 105612
              }
            ]
          }
        ],
        "alternatives": []
      },
      {
        "report_key": "2024:q4",
        "period_label": "2024 Q4",
        "date": "2025-02-05",
        "title": "Kvartalsrapport Q4 2024",
        "original_title": "Bokslutskommuniké 1 januari - 31 december 2024",
        "category": "Bokslutskommuniké",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://view.news.eu.nasdaq.com/view?id=bd66d560eb0ef55b36c7c36ebbb7ce8d7&lang=sv&src=listed",
        "language": "sv",
        "report_type": "year-end-report",
        "fiscal_year": 2024,
        "quarter": "q4",
        "documents": [
          {
            "doc_id": "nasdaq-nordic-kvartalsrapport-q4-2024",
            "title": "Kvartalsrapport Q4 2024",
            "source": "Nasdaq Nordic",
            "source_class": "nasdaq-report",
            "source_url": "https://attachment.news.eu.nasdaq.com/a1f3af771049d2ccfe7dbfab35a891606",
            "date": "2025-02-05",
            "period": "2024-q4",
            "form_type": "year-end-report",
            "report_key": "2024:q4",
            "filename": "02042157.pdf",
            "text_chars": 41954,
            "sha256": "b5a11beb27fe3efde2a47b3fdd804df75dd2ca4c18fcb40c20d135ddda461477",
            "url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q4-2024",
            "absolute_url": "https://spela.port0.org/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q4-2024",
            "txt_url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q4-2024/fulltext.txt",
            "absolute_txt_url": "https://spela.port0.org/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q4-2024/fulltext.txt",
            "parts": [
              {
                "number": 1,
                "url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q4-2024/part-001.html",
                "chars": 41954
              }
            ]
          }
        ],
        "alternatives": []
      },
      {
        "report_key": "2024:q3",
        "period_label": "2024 Q3",
        "date": "2024-10-25",
        "title": "Kvartalsrapport Q3 2024",
        "original_title": "Delårsrapport 1 januari - 30 september 2024",
        "category": "Interimsrapport",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://view.news.eu.nasdaq.com/view?id=bb9902a842c2af51a0454de22f10b76bb&lang=sv&src=listed",
        "language": "sv",
        "report_type": "interim-report",
        "fiscal_year": 2024,
        "quarter": "q3",
        "documents": [
          {
            "doc_id": "nasdaq-nordic-kvartalsrapport-q3-2024",
            "title": "Kvartalsrapport Q3 2024",
            "source": "Nasdaq Nordic",
            "source_class": "nasdaq-report",
            "source_url": "https://attachment.news.eu.nasdaq.com/a06d68daf7ae64e385c246f482cc074ba",
            "date": "2024-10-25",
            "period": "2024-q3",
            "form_type": "interim-report",
            "report_key": "2024:q3",
            "filename": "10247432.pdf",
            "text_chars": 44738,
            "sha256": "14fa98a3ab928429690d7871bcf1ae6652f53ccf1e527d17b84206f2ee01c4e6",
            "url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q3-2024",
            "absolute_url": "https://spela.port0.org/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q3-2024",
            "txt_url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q3-2024/fulltext.txt",
            "absolute_txt_url": "https://spela.port0.org/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q3-2024/fulltext.txt",
            "parts": [
              {
                "number": 1,
                "url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q3-2024/part-001.html",
                "chars": 44738
              }
            ]
          }
        ],
        "alternatives": []
      },
      {
        "report_key": "2024:q2",
        "period_label": "2024 Q2",
        "date": "2024-07-12",
        "title": "Kvartalsrapport Q2 2024",
        "original_title": "DELÅRSRAPPORT 1 JANUARI - 30 JUNI 2024",
        "category": "Halvårsrapport",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://view.news.eu.nasdaq.com/view?id=b80e29f315ac67e940e6ff2dc5dd86a8c&lang=sv&src=listed",
        "language": "sv",
        "report_type": "interim-report",
        "fiscal_year": 2024,
        "quarter": "q2",
        "documents": [
          {
            "doc_id": "nasdaq-nordic-kvartalsrapport-q2-2024",
            "title": "Kvartalsrapport Q2 2024",
            "source": "Nasdaq Nordic",
            "source_class": "nasdaq-report",
            "source_url": "https://attachment.news.eu.nasdaq.com/a6a2d11acb4897d1de569de15eec47bc7",
            "date": "2024-07-12",
            "period": "2024-q2",
            "form_type": "interim-report",
            "report_key": "2024:q2",
            "filename": "07114860.pdf",
            "text_chars": 41780,
            "sha256": "83eca184a4597906e0794eab275f815da5c0193c770926d1c29368dbf1df2c9a",
            "url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2024",
            "absolute_url": "https://spela.port0.org/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2024",
            "txt_url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2024/fulltext.txt",
            "absolute_txt_url": "https://spela.port0.org/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2024/fulltext.txt",
            "parts": [
              {
                "number": 1,
                "url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2024/part-001.html",
                "chars": 41780
              }
            ]
          }
        ],
        "alternatives": []
      },
      {
        "report_key": "2024:q1",
        "period_label": "2024 Q1",
        "date": "2024-04-24",
        "title": "Kvartalsrapport Q1 2024",
        "original_title": "DELÅRSRAPPORT 1 JANUARI - 31 MARS 2024",
        "category": "Interimsrapport",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://view.news.eu.nasdaq.com/view?id=b1f224de67bca57f2c21c24cd6eaf520c&lang=sv&src=listed",
        "language": "sv",
        "report_type": "interim-report",
        "fiscal_year": 2024,
        "quarter": "q1",
        "documents": [
          {
            "doc_id": "nasdaq-nordic-kvartalsrapport-q1-2024",
            "title": "Kvartalsrapport Q1 2024",
            "source": "Nasdaq Nordic",
            "source_class": "nasdaq-report",
            "source_url": "https://attachment.news.eu.nasdaq.com/a7a36e40e82ac82dc2446c736bd9321ad",
            "date": "2024-04-24",
            "period": "2024-q1",
            "form_type": "interim-report",
            "report_key": "2024:q1",
            "filename": "04236511.pdf",
            "text_chars": 39221,
            "sha256": "b13ec861cf9e4818e4f9fb1e699988603eb9495627c5f2fb55f7860c1d7d8e28",
            "url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2024",
            "absolute_url": "https://spela.port0.org/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2024",
            "txt_url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2024/fulltext.txt",
            "absolute_txt_url": "https://spela.port0.org/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2024/fulltext.txt",
            "parts": [
              {
                "number": 1,
                "url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2024/part-001.html",
                "chars": 39221
              }
            ]
          }
        ],
        "alternatives": []
      },
      {
        "report_key": "2023:annual",
        "period_label": "2023 Årsredovisning",
        "date": "2024-03-07",
        "title": "Årsredovisning 2023",
        "original_title": "Episurf Medical AB publicerar årsredovisning för 2023",
        "category": "Bokslut och Verksamhetsberättelse",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://view.news.eu.nasdaq.com/view?id=b7c8de5b94e440ab09004ffa3516c8523&lang=sv&src=listed",
        "language": "sv",
        "report_type": "annual-report",
        "fiscal_year": 2023,
        "quarter": "annual",
        "documents": [
          {
            "doc_id": "nasdaq-nordic-arsredovisning-2023",
            "title": "Årsredovisning 2023",
            "source": "Nasdaq Nordic",
            "source_class": "nasdaq-report",
            "source_url": "https://attachment.news.eu.nasdaq.com/acbe979e0c81f89598f27cd4285c03d4a",
            "date": "2024-03-07",
            "period": "2023-annual",
            "form_type": "annual-report",
            "report_key": "2023:annual",
            "filename": "03072581.pdf",
            "text_chars": 288926,
            "sha256": "139cf444afd331abccb74ba0d1f7a563ede9bc0029ddeea094e71af4e3e709a6",
            "url": "/company/episurf-medical-ab/documents/nasdaq-nordic-arsredovisning-2023",
            "absolute_url": "https://spela.port0.org/company/episurf-medical-ab/documents/nasdaq-nordic-arsredovisning-2023",
            "txt_url": "/company/episurf-medical-ab/documents/nasdaq-nordic-arsredovisning-2023/fulltext.txt",
            "absolute_txt_url": "https://spela.port0.org/company/episurf-medical-ab/documents/nasdaq-nordic-arsredovisning-2023/fulltext.txt",
            "parts": [
              {
                "number": 1,
                "url": "/company/episurf-medical-ab/documents/nasdaq-nordic-arsredovisning-2023/part-001.html",
                "chars": 178677
              },
              {
                "number": 2,
                "url": "/company/episurf-medical-ab/documents/nasdaq-nordic-arsredovisning-2023/part-002.html",
                "chars": 110247
              }
            ]
          }
        ],
        "alternatives": []
      },
      {
        "report_key": "2023:q4",
        "period_label": "2023 Q4",
        "date": "2024-02-09",
        "title": "Kvartalsrapport Q4 2023",
        "original_title": "BOKSLUTSKOMMUNIKÉ 1 JANUARI - 31 DECEMBER 2023",
        "category": "Bokslutskommuniké",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://view.news.eu.nasdaq.com/view?id=bdf35a0d9eb0277f6313daf14902dcb03&lang=sv&src=listed",
        "language": "sv",
        "report_type": "year-end-report",
        "fiscal_year": 2023,
        "quarter": "q4",
        "documents": [
          {
            "doc_id": "nasdaq-nordic-kvartalsrapport-q4-2023",
            "title": "Kvartalsrapport Q4 2023",
            "source": "Nasdaq Nordic",
            "source_class": "nasdaq-report",
            "source_url": "https://attachment.news.eu.nasdaq.com/a52f36b84a728bf9f93a768652b782465",
            "date": "2024-02-09",
            "period": "2023-q4",
            "form_type": "year-end-report",
            "report_key": "2023:q4",
            "filename": "02085164.pdf",
            "text_chars": 40883,
            "sha256": "963175a0cae339404ee7f5d50c015bf3c357bee6ec60876c6ca4685c52b3a9f5",
            "url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q4-2023",
            "absolute_url": "https://spela.port0.org/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q4-2023",
            "txt_url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q4-2023/fulltext.txt",
            "absolute_txt_url": "https://spela.port0.org/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q4-2023/fulltext.txt",
            "parts": [
              {
                "number": 1,
                "url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q4-2023/part-001.html",
                "chars": 40883
              }
            ]
          }
        ],
        "alternatives": []
      },
      {
        "report_key": "2023:q3",
        "period_label": "2023 Q3",
        "date": "2023-10-27",
        "title": "Kvartalsrapport Q3 2023",
        "original_title": "DELÅRSRAPPORT 1 JANUARI - 30 SEPTEMBER 2023",
        "category": "Interimsrapport",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://view.news.eu.nasdaq.com/view?id=b127be84e3c9301d02221e9551be65e28&lang=sv&src=listed",
        "language": "sv",
        "report_type": "interim-report",
        "fiscal_year": 2023,
        "quarter": "q3",
        "documents": [
          {
            "doc_id": "nasdaq-nordic-kvartalsrapport-q3-2023",
            "title": "Kvartalsrapport Q3 2023",
            "source": "Nasdaq Nordic",
            "source_class": "nasdaq-report",
            "source_url": "https://attachment.news.eu.nasdaq.com/a8ba90b376b7b000a0c7f7c1cea1bf132",
            "date": "2023-10-27",
            "period": "2023-q3",
            "form_type": "interim-report",
            "report_key": "2023:q3",
            "filename": "10263062.pdf",
            "text_chars": 43445,
            "sha256": "159810e20f79e6b8554fc810a4e64c7d5a6b12e079ee0cacc088142454df6ec1",
            "url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q3-2023",
            "absolute_url": "https://spela.port0.org/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q3-2023",
            "txt_url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q3-2023/fulltext.txt",
            "absolute_txt_url": "https://spela.port0.org/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q3-2023/fulltext.txt",
            "parts": [
              {
                "number": 1,
                "url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q3-2023/part-001.html",
                "chars": 43445
              }
            ]
          }
        ],
        "alternatives": []
      },
      {
        "report_key": "2023:q2",
        "period_label": "2023 Q2",
        "date": "2023-07-14",
        "title": "Kvartalsrapport Q2 2023",
        "original_title": "Delårsrapport 1 januari - 30 juni 2023",
        "category": "Halvårsrapport",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://view.news.eu.nasdaq.com/view?id=bb0fb3d67258eaddb2e7546c8a2a03740&lang=sv&src=listed",
        "language": "sv",
        "report_type": "interim-report",
        "fiscal_year": 2023,
        "quarter": "q2",
        "documents": [
          {
            "doc_id": "nasdaq-nordic-kvartalsrapport-q2-2023",
            "title": "Kvartalsrapport Q2 2023",
            "source": "Nasdaq Nordic",
            "source_class": "nasdaq-report",
            "source_url": "https://attachment.news.eu.nasdaq.com/a1e9d925eb1bcdc5f8940c8c70a486cb7",
            "date": "2023-07-14",
            "period": "2023-q2",
            "form_type": "interim-report",
            "report_key": "2023:q2",
            "filename": "07133448.pdf",
            "text_chars": 43490,
            "sha256": "214d155efff34ae01856d9c3f35cef58fd458df12920d8c0a5273e6d334acf8b",
            "url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2023",
            "absolute_url": "https://spela.port0.org/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2023",
            "txt_url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2023/fulltext.txt",
            "absolute_txt_url": "https://spela.port0.org/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2023/fulltext.txt",
            "parts": [
              {
                "number": 1,
                "url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2023/part-001.html",
                "chars": 43490
              }
            ]
          }
        ],
        "alternatives": []
      },
      {
        "report_key": "2023:q1",
        "period_label": "2023 Q1",
        "date": "2023-04-28",
        "title": "Kvartalsrapport Q1 2023",
        "original_title": "Delårsrapport 1 januari - 31 mars 2023",
        "category": "Interimsrapport",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://view.news.eu.nasdaq.com/view?id=b3653d4b260e2aba8f768d542b131dfa3&lang=sv&src=listed",
        "language": "sv",
        "report_type": "interim-report",
        "fiscal_year": 2023,
        "quarter": "q1",
        "documents": [
          {
            "doc_id": "nasdaq-nordic-kvartalsrapport-q1-2023",
            "title": "Kvartalsrapport Q1 2023",
            "source": "Nasdaq Nordic",
            "source_class": "nasdaq-report",
            "source_url": "https://attachment.news.eu.nasdaq.com/aa27343098804155dab684a735ac775fb",
            "date": "2023-04-28",
            "period": "2023-q1",
            "form_type": "interim-report",
            "report_key": "2023:q1",
            "filename": "04278325.pdf",
            "text_chars": 38866,
            "sha256": "769a8e31fad3c087af20f15ca96f98cfcad5714bbae2ae3146c16b6af816131e",
            "url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2023",
            "absolute_url": "https://spela.port0.org/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2023",
            "txt_url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2023/fulltext.txt",
            "absolute_txt_url": "https://spela.port0.org/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2023/fulltext.txt",
            "parts": [
              {
                "number": 1,
                "url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2023/part-001.html",
                "chars": 38866
              }
            ]
          }
        ],
        "alternatives": []
      }
    ]
  },
  "report_count": 16,
  "nasdaq_report_count": 16,
  "mfn_fallback_count": 0,
  "sec_status": "skipped",
  "sec_count": 0,
  "fi_status": "retrieved",
  "fi_summary": {
    "company": "Episurf Medical AB",
    "identity": {
      "issuer": "Sedana Medical AB (publ)",
      "lei": "549300FQ3NJRI56LCX32",
      "source": "FI aggregerade blankningspositioner",
      "row_count": 12,
      "score": 50.0,
      "status": "resolved",
      "requested_company": "Episurf Medical AB",
      "query": "Sedana Medical AB (publ)",
      "candidate_count": 345
    },
    "period": {
      "from": "2024-08-07",
      "to": "2026-08-07",
      "years": 2
    },
    "generated_at": "2026-08-07T03:19:48Z",
    "insider": {
      "transactions": 11,
      "all_export_rows": 11,
      "acquisitions": 8,
      "disposals": 3,
      "other": 0,
      "acquisition_value_sek": 3813095.46,
      "disposal_value_sek": 1808131.55,
      "characters": {
        "Avyttring": 3,
        "Förvärv": 8
      }
    },
    "short_selling": {
      "aggregate_percent": 2.26,
      "current_public_positions": 1,
      "historical_changes": 35,
      "current_position_sum_over_0_5": 0.8
    },
    "sources": {
      "insider_register": "https://www.fi.se/sv/vara-register/insynsregistret/",
      "short_register": "https://www.fi.se/sv/vara-register/blankningsregistret/"
    }
  },
  "warnings": [
    "MFN fallback: resolved_no_reports"
  ],
  "source_identity": {
    "nasdaq_reports": {
      "slug": "",
      "instrument_id": "TX712898",
      "resolved_url": "https://www.nasdaq.com/european-market-activity/shares/epis-b?id=TX712898"
    },
    "mfn": {
      "status": "resolved",
      "company_name": "Episurf Medical",
      "expected_name": "Episurf Medical AB",
      "match_score": 100.0,
      "slug": "episurf-medical",
      "url": "https://mfn.se/all/a/episurf-medical",
      "metadata": {
        "country": "Sverige",
        "list": "Small Cap Stockholm",
        "sector": "Hälsovård",
        "industry": "Medicinteknik",
        "website": "https://mb.cision.com/Main/14691/4370964/4180658.pdf"
      },
      "ticker_candidates": [],
      "attempts": [
        {
          "slug": "episurf-medical-ab",
          "url": "https://mfn.se/all/a/episurf-medical-ab",
          "status": "identity_mismatch",
          "title": "",
          "score": 0.0
        }
      ]
    },
    "sec": null,
    "nasdaq": {
      "instrument_id": "TX712898",
      "asset_class": "SHARES",
      "isin": "SE0003491562",
      "symbol": "EPIS B",
      "company": "Episurf B",
      "market": null,
      "last_sale_price": "SEK 0.0607",
      "time_as_of": "2026-08-06"
    },
    "finansinspektionen": {
      "issuer": "Sedana Medical AB (publ)",
      "lei": "549300FQ3NJRI56LCX32",
      "source": "FI aggregerade blankningspositioner",
      "row_count": 12,
      "score": 50.0,
      "status": "resolved",
      "requested_company": "Episurf Medical AB",
      "query": "Sedana Medical AB (publ)",
      "candidate_count": 345
    }
  },
  "documents": [
    {
      "doc_id": "nasdaq-nordic-kvartalsrapport-q1-2026",
      "title": "Kvartalsrapport Q1 2026",
      "source": "Nasdaq Nordic",
      "source_class": "nasdaq-report",
      "source_url": "https://attachment.news.eu.nasdaq.com/aab8a43e74fee5eace7bce8c45a8620f8",
      "date": "2026-05-25",
      "period": "2026-q1",
      "form_type": "interim-report",
      "report_key": "2026:q1",
      "filename": "05256593.pdf",
      "text_chars": 33267,
      "sha256": "5d82cf9d28de6d24fe2cafdcf299b47e6f69cf52c5ded7e4ce7ab0083547a295",
      "url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2026",
      "absolute_url": "https://spela.port0.org/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2026",
      "txt_url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2026/fulltext.txt",
      "absolute_txt_url": "https://spela.port0.org/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2026/fulltext.txt",
      "parts": [
        {
          "number": 1,
          "url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2026/part-001.html",
          "chars": 33267
        }
      ]
    },
    {
      "doc_id": "nasdaq-nordic-arsredovisning-2025",
      "title": "Årsredovisning 2025",
      "source": "Nasdaq Nordic",
      "source_class": "nasdaq-report",
      "source_url": "https://attachment.news.eu.nasdaq.com/a81b93c940a2b2561fb907e5d4868092e",
      "date": "2026-03-20",
      "period": "2025-annual",
      "form_type": "annual-report",
      "report_key": "2025:annual",
      "filename": "03207922.pdf",
      "text_chars": 284791,
      "sha256": "98f52adea34923f38cbece510aa866da6c82126f0c580e5291cbb9abdb60f0f5",
      "url": "/company/episurf-medical-ab/documents/nasdaq-nordic-arsredovisning-2025",
      "absolute_url": "https://spela.port0.org/company/episurf-medical-ab/documents/nasdaq-nordic-arsredovisning-2025",
      "txt_url": "/company/episurf-medical-ab/documents/nasdaq-nordic-arsredovisning-2025/fulltext.txt",
      "absolute_txt_url": "https://spela.port0.org/company/episurf-medical-ab/documents/nasdaq-nordic-arsredovisning-2025/fulltext.txt",
      "parts": [
        {
          "number": 1,
          "url": "/company/episurf-medical-ab/documents/nasdaq-nordic-arsredovisning-2025/part-001.html",
          "chars": 179732
        },
        {
          "number": 2,
          "url": "/company/episurf-medical-ab/documents/nasdaq-nordic-arsredovisning-2025/part-002.html",
          "chars": 105057
        }
      ]
    },
    {
      "doc_id": "nasdaq-nordic-kvartalsrapport-q4-2025",
      "title": "Kvartalsrapport Q4 2025",
      "source": "Nasdaq Nordic",
      "source_class": "nasdaq-report",
      "source_url": "https://attachment.news.eu.nasdaq.com/a1bb32b8b6f7e30d498619f54e258bf24",
      "date": "2026-02-06",
      "period": "2025-q4",
      "form_type": "year-end-report",
      "report_key": "2025:q4",
      "filename": "02045726.pdf",
      "text_chars": 43151,
      "sha256": "c388d1c855910f4f5c9ba52e62b0685e49760c8f452685d125a74a427e4870b5",
      "url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q4-2025",
      "absolute_url": "https://spela.port0.org/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q4-2025",
      "txt_url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q4-2025/fulltext.txt",
      "absolute_txt_url": "https://spela.port0.org/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q4-2025/fulltext.txt",
      "parts": [
        {
          "number": 1,
          "url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q4-2025/part-001.html",
          "chars": 43151
        }
      ]
    },
    {
      "doc_id": "nasdaq-nordic-kvartalsrapport-q3-2025",
      "title": "Kvartalsrapport Q3 2025",
      "source": "Nasdaq Nordic",
      "source_class": "nasdaq-report",
      "source_url": "https://attachment.news.eu.nasdaq.com/a60352723909d02bdb354d97cd07a8fe0",
      "date": "2025-10-24",
      "period": "2025-q3",
      "form_type": "interim-report",
      "report_key": "2025:q3",
      "filename": "10238921.pdf",
      "text_chars": 46826,
      "sha256": "9b9ee7842ea7c3f79acd844498db660d1369325111fd9f9fc529dacb619a69bc",
      "url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q3-2025",
      "absolute_url": "https://spela.port0.org/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q3-2025",
      "txt_url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q3-2025/fulltext.txt",
      "absolute_txt_url": "https://spela.port0.org/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q3-2025/fulltext.txt",
      "parts": [
        {
          "number": 1,
          "url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q3-2025/part-001.html",
          "chars": 46826
        }
      ]
    },
    {
      "doc_id": "nasdaq-nordic-kvartalsrapport-q2-2025",
      "title": "Kvartalsrapport Q2 2025",
      "source": "Nasdaq Nordic",
      "source_class": "nasdaq-report",
      "source_url": "https://attachment.news.eu.nasdaq.com/a97b92923ca6221d0b7b355374cdf8c11",
      "date": "2025-07-11",
      "period": "2025-q2",
      "form_type": "interim-report",
      "report_key": "2025:q2",
      "filename": "07108252.pdf",
      "text_chars": 42301,
      "sha256": "fed67fa327fcc0fe2a3c219c8466c92a00c08a61a455f69b30fe40078b228b88",
      "url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2025",
      "absolute_url": "https://spela.port0.org/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2025",
      "txt_url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2025/fulltext.txt",
      "absolute_txt_url": "https://spela.port0.org/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2025/fulltext.txt",
      "parts": [
        {
          "number": 1,
          "url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2025/part-001.html",
          "chars": 42301
        }
      ]
    },
    {
      "doc_id": "nasdaq-nordic-kvartalsrapport-q1-2025",
      "title": "Kvartalsrapport Q1 2025",
      "source": "Nasdaq Nordic",
      "source_class": "nasdaq-report",
      "source_url": "https://attachment.news.eu.nasdaq.com/aa09ea965d322c5501bb7401ee50c54b3",
      "date": "2025-04-10",
      "period": "2025-q1",
      "form_type": "interim-report",
      "report_key": "2025:q1",
      "filename": "04095665.pdf",
      "text_chars": 39392,
      "sha256": "1c826e86f766fb0916829100e81db6fc31b0edf779f85409a6d3e5c00a2bafd8",
      "url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2025",
      "absolute_url": "https://spela.port0.org/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2025",
      "txt_url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2025/fulltext.txt",
      "absolute_txt_url": "https://spela.port0.org/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2025/fulltext.txt",
      "parts": [
        {
          "number": 1,
          "url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2025/part-001.html",
          "chars": 39392
        }
      ]
    },
    {
      "doc_id": "nasdaq-nordic-arsredovisning-2024",
      "title": "Årsredovisning 2024",
      "source": "Nasdaq Nordic",
      "source_class": "nasdaq-report",
      "source_url": "https://attachment.news.eu.nasdaq.com/a8a25e81acbd157814da20927ed5b497e",
      "date": "2025-03-06",
      "period": "2024-annual",
      "form_type": "annual-report",
      "report_key": "2024:annual",
      "filename": "03067038.pdf",
      "text_chars": 284435,
      "sha256": "0d541124ef181df99beb4ec4704da40d9ab287a48f1aeb6b3a6a71caa17206f3",
      "url": "/company/episurf-medical-ab/documents/nasdaq-nordic-arsredovisning-2024",
      "absolute_url": "https://spela.port0.org/company/episurf-medical-ab/documents/nasdaq-nordic-arsredovisning-2024",
      "txt_url": "/company/episurf-medical-ab/documents/nasdaq-nordic-arsredovisning-2024/fulltext.txt",
      "absolute_txt_url": "https://spela.port0.org/company/episurf-medical-ab/documents/nasdaq-nordic-arsredovisning-2024/fulltext.txt",
      "parts": [
        {
          "number": 1,
          "url": "/company/episurf-medical-ab/documents/nasdaq-nordic-arsredovisning-2024/part-001.html",
          "chars": 178821
        },
        {
          "number": 2,
          "url": "/company/episurf-medical-ab/documents/nasdaq-nordic-arsredovisning-2024/part-002.html",
          "chars": 105612
        }
      ]
    },
    {
      "doc_id": "nasdaq-nordic-kvartalsrapport-q4-2024",
      "title": "Kvartalsrapport Q4 2024",
      "source": "Nasdaq Nordic",
      "source_class": "nasdaq-report",
      "source_url": "https://attachment.news.eu.nasdaq.com/a1f3af771049d2ccfe7dbfab35a891606",
      "date": "2025-02-05",
      "period": "2024-q4",
      "form_type": "year-end-report",
      "report_key": "2024:q4",
      "filename": "02042157.pdf",
      "text_chars": 41954,
      "sha256": "b5a11beb27fe3efde2a47b3fdd804df75dd2ca4c18fcb40c20d135ddda461477",
      "url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q4-2024",
      "absolute_url": "https://spela.port0.org/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q4-2024",
      "txt_url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q4-2024/fulltext.txt",
      "absolute_txt_url": "https://spela.port0.org/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q4-2024/fulltext.txt",
      "parts": [
        {
          "number": 1,
          "url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q4-2024/part-001.html",
          "chars": 41954
        }
      ]
    },
    {
      "doc_id": "nasdaq-nordic-kvartalsrapport-q3-2024",
      "title": "Kvartalsrapport Q3 2024",
      "source": "Nasdaq Nordic",
      "source_class": "nasdaq-report",
      "source_url": "https://attachment.news.eu.nasdaq.com/a06d68daf7ae64e385c246f482cc074ba",
      "date": "2024-10-25",
      "period": "2024-q3",
      "form_type": "interim-report",
      "report_key": "2024:q3",
      "filename": "10247432.pdf",
      "text_chars": 44738,
      "sha256": "14fa98a3ab928429690d7871bcf1ae6652f53ccf1e527d17b84206f2ee01c4e6",
      "url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q3-2024",
      "absolute_url": "https://spela.port0.org/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q3-2024",
      "txt_url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q3-2024/fulltext.txt",
      "absolute_txt_url": "https://spela.port0.org/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q3-2024/fulltext.txt",
      "parts": [
        {
          "number": 1,
          "url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q3-2024/part-001.html",
          "chars": 44738
        }
      ]
    },
    {
      "doc_id": "nasdaq-nordic-kvartalsrapport-q2-2024",
      "title": "Kvartalsrapport Q2 2024",
      "source": "Nasdaq Nordic",
      "source_class": "nasdaq-report",
      "source_url": "https://attachment.news.eu.nasdaq.com/a6a2d11acb4897d1de569de15eec47bc7",
      "date": "2024-07-12",
      "period": "2024-q2",
      "form_type": "interim-report",
      "report_key": "2024:q2",
      "filename": "07114860.pdf",
      "text_chars": 41780,
      "sha256": "83eca184a4597906e0794eab275f815da5c0193c770926d1c29368dbf1df2c9a",
      "url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2024",
      "absolute_url": "https://spela.port0.org/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2024",
      "txt_url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2024/fulltext.txt",
      "absolute_txt_url": "https://spela.port0.org/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2024/fulltext.txt",
      "parts": [
        {
          "number": 1,
          "url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2024/part-001.html",
          "chars": 41780
        }
      ]
    },
    {
      "doc_id": "nasdaq-nordic-kvartalsrapport-q1-2024",
      "title": "Kvartalsrapport Q1 2024",
      "source": "Nasdaq Nordic",
      "source_class": "nasdaq-report",
      "source_url": "https://attachment.news.eu.nasdaq.com/a7a36e40e82ac82dc2446c736bd9321ad",
      "date": "2024-04-24",
      "period": "2024-q1",
      "form_type": "interim-report",
      "report_key": "2024:q1",
      "filename": "04236511.pdf",
      "text_chars": 39221,
      "sha256": "b13ec861cf9e4818e4f9fb1e699988603eb9495627c5f2fb55f7860c1d7d8e28",
      "url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2024",
      "absolute_url": "https://spela.port0.org/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2024",
      "txt_url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2024/fulltext.txt",
      "absolute_txt_url": "https://spela.port0.org/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2024/fulltext.txt",
      "parts": [
        {
          "number": 1,
          "url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2024/part-001.html",
          "chars": 39221
        }
      ]
    },
    {
      "doc_id": "nasdaq-nordic-arsredovisning-2023",
      "title": "Årsredovisning 2023",
      "source": "Nasdaq Nordic",
      "source_class": "nasdaq-report",
      "source_url": "https://attachment.news.eu.nasdaq.com/acbe979e0c81f89598f27cd4285c03d4a",
      "date": "2024-03-07",
      "period": "2023-annual",
      "form_type": "annual-report",
      "report_key": "2023:annual",
      "filename": "03072581.pdf",
      "text_chars": 288926,
      "sha256": "139cf444afd331abccb74ba0d1f7a563ede9bc0029ddeea094e71af4e3e709a6",
      "url": "/company/episurf-medical-ab/documents/nasdaq-nordic-arsredovisning-2023",
      "absolute_url": "https://spela.port0.org/company/episurf-medical-ab/documents/nasdaq-nordic-arsredovisning-2023",
      "txt_url": "/company/episurf-medical-ab/documents/nasdaq-nordic-arsredovisning-2023/fulltext.txt",
      "absolute_txt_url": "https://spela.port0.org/company/episurf-medical-ab/documents/nasdaq-nordic-arsredovisning-2023/fulltext.txt",
      "parts": [
        {
          "number": 1,
          "url": "/company/episurf-medical-ab/documents/nasdaq-nordic-arsredovisning-2023/part-001.html",
          "chars": 178677
        },
        {
          "number": 2,
          "url": "/company/episurf-medical-ab/documents/nasdaq-nordic-arsredovisning-2023/part-002.html",
          "chars": 110247
        }
      ]
    },
    {
      "doc_id": "nasdaq-nordic-kvartalsrapport-q4-2023",
      "title": "Kvartalsrapport Q4 2023",
      "source": "Nasdaq Nordic",
      "source_class": "nasdaq-report",
      "source_url": "https://attachment.news.eu.nasdaq.com/a52f36b84a728bf9f93a768652b782465",
      "date": "2024-02-09",
      "period": "2023-q4",
      "form_type": "year-end-report",
      "report_key": "2023:q4",
      "filename": "02085164.pdf",
      "text_chars": 40883,
      "sha256": "963175a0cae339404ee7f5d50c015bf3c357bee6ec60876c6ca4685c52b3a9f5",
      "url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q4-2023",
      "absolute_url": "https://spela.port0.org/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q4-2023",
      "txt_url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q4-2023/fulltext.txt",
      "absolute_txt_url": "https://spela.port0.org/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q4-2023/fulltext.txt",
      "parts": [
        {
          "number": 1,
          "url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q4-2023/part-001.html",
          "chars": 40883
        }
      ]
    },
    {
      "doc_id": "nasdaq-nordic-kvartalsrapport-q3-2023",
      "title": "Kvartalsrapport Q3 2023",
      "source": "Nasdaq Nordic",
      "source_class": "nasdaq-report",
      "source_url": "https://attachment.news.eu.nasdaq.com/a8ba90b376b7b000a0c7f7c1cea1bf132",
      "date": "2023-10-27",
      "period": "2023-q3",
      "form_type": "interim-report",
      "report_key": "2023:q3",
      "filename": "10263062.pdf",
      "text_chars": 43445,
      "sha256": "159810e20f79e6b8554fc810a4e64c7d5a6b12e079ee0cacc088142454df6ec1",
      "url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q3-2023",
      "absolute_url": "https://spela.port0.org/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q3-2023",
      "txt_url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q3-2023/fulltext.txt",
      "absolute_txt_url": "https://spela.port0.org/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q3-2023/fulltext.txt",
      "parts": [
        {
          "number": 1,
          "url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q3-2023/part-001.html",
          "chars": 43445
        }
      ]
    },
    {
      "doc_id": "nasdaq-nordic-kvartalsrapport-q2-2023",
      "title": "Kvartalsrapport Q2 2023",
      "source": "Nasdaq Nordic",
      "source_class": "nasdaq-report",
      "source_url": "https://attachment.news.eu.nasdaq.com/a1e9d925eb1bcdc5f8940c8c70a486cb7",
      "date": "2023-07-14",
      "period": "2023-q2",
      "form_type": "interim-report",
      "report_key": "2023:q2",
      "filename": "07133448.pdf",
      "text_chars": 43490,
      "sha256": "214d155efff34ae01856d9c3f35cef58fd458df12920d8c0a5273e6d334acf8b",
      "url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2023",
      "absolute_url": "https://spela.port0.org/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2023",
      "txt_url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2023/fulltext.txt",
      "absolute_txt_url": "https://spela.port0.org/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2023/fulltext.txt",
      "parts": [
        {
          "number": 1,
          "url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2023/part-001.html",
          "chars": 43490
        }
      ]
    },
    {
      "doc_id": "nasdaq-nordic-kvartalsrapport-q1-2023",
      "title": "Kvartalsrapport Q1 2023",
      "source": "Nasdaq Nordic",
      "source_class": "nasdaq-report",
      "source_url": "https://attachment.news.eu.nasdaq.com/aa27343098804155dab684a735ac775fb",
      "date": "2023-04-28",
      "period": "2023-q1",
      "form_type": "interim-report",
      "report_key": "2023:q1",
      "filename": "04278325.pdf",
      "text_chars": 38866,
      "sha256": "769a8e31fad3c087af20f15ca96f98cfcad5714bbae2ae3146c16b6af816131e",
      "url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2023",
      "absolute_url": "https://spela.port0.org/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2023",
      "txt_url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2023/fulltext.txt",
      "absolute_txt_url": "https://spela.port0.org/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2023/fulltext.txt",
      "parts": [
        {
          "number": 1,
          "url": "/company/episurf-medical-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2023/part-001.html",
          "chars": 38866
        }
      ]
    },
    {
      "doc_id": "mfn-mfn-bolagssida-och-bolagsmetadata",
      "title": "MFN bolagssida och bolagsmetadata",
      "source": "MFN",
      "source_class": "mfn",
      "source_url": "https://mfn.se/all/a/episurf-medical",
      "date": null,
      "period": null,
      "form_type": "company-page",
      "report_key": null,
      "filename": "company.txt",
      "text_chars": 15127,
      "sha256": "32c2ee05bd13fa8f03734c32f344f006f5b749795a495c72b38f92cebd318d07",
      "url": "/company/episurf-medical-ab/documents/mfn-mfn-bolagssida-och-bolagsmetadata",
      "absolute_url": "https://spela.port0.org/company/episurf-medical-ab/documents/mfn-mfn-bolagssida-och-bolagsmetadata",
      "txt_url": "/company/episurf-medical-ab/documents/mfn-mfn-bolagssida-och-bolagsmetadata/fulltext.txt",
      "absolute_txt_url": "https://spela.port0.org/company/episurf-medical-ab/documents/mfn-mfn-bolagssida-och-bolagsmetadata/fulltext.txt",
      "parts": [
        {
          "number": 1,
          "url": "/company/episurf-medical-ab/documents/mfn-mfn-bolagssida-och-bolagsmetadata/part-001.html",
          "chars": 15127
        }
      ]
    }
  ],
  "market_files": [
    {
      "label": "Nasdaq kurshistorik CSV",
      "url": "/company/episurf-medical-ab/market/history.csv",
      "absolute_url": "https://spela.port0.org/company/episurf-medical-ab/market/history.csv"
    },
    {
      "label": "Nasdaq kurshistorik JSON",
      "url": "/company/episurf-medical-ab/market/history.json",
      "absolute_url": "https://spela.port0.org/company/episurf-medical-ab/market/history.json"
    },
    {
      "label": "Nasdaq manifest JSON",
      "url": "/company/episurf-medical-ab/market/manifest.json",
      "absolute_url": "https://spela.port0.org/company/episurf-medical-ab/market/manifest.json"
    },
    {
      "label": "Nasdaq instrumentidentitet JSON",
      "url": "/company/episurf-medical-ab/market/instrument.json",
      "absolute_url": "https://spela.port0.org/company/episurf-medical-ab/market/instrument.json"
    },
    {
      "label": "MFN manifest JSON",
      "url": "/company/episurf-medical-ab/market/mfn-manifest.json",
      "absolute_url": "https://spela.port0.org/company/episurf-medical-ab/market/mfn-manifest.json"
    },
    {
      "label": "Nasdaq rapportmanifest JSON",
      "url": "/company/episurf-medical-ab/market/nasdaq-reports-manifest.json",
      "absolute_url": "https://spela.port0.org/company/episurf-medical-ab/market/nasdaq-reports-manifest.json"
    }
  ],
  "sec_facts": {
    "status": "missing",
    "metrics": []
  },
  "morningstar": {
    "configured": false,
    "status": "inte hämtad",
    "captured_at": null,
    "view_count": 0,
    "url": "/company/episurf-medical-ab/morningstar"
  },
  "finansinspektionen": {
    "available": true,
    "status": "retrieved",
    "url": "/company/episurf-medical-ab/finansinspektionen",
    "transaction_count": 11,
    "aggregate_short_percent": 2.26,
    "files": [
      {
        "filename": "summary.json",
        "label": "Sammanfattning JSON",
        "url": "summary.json"
      },
      {
        "filename": "insider-transactions.csv",
        "label": "Insynstransaktioner CSV",
        "url": "insider-transactions.csv"
      },
      {
        "filename": "insider-transactions.json",
        "label": "Insynstransaktioner JSON",
        "url": "insider-transactions.json"
      },
      {
        "filename": "short-current.json",
        "label": "Aktuella blankningspositioner JSON",
        "url": "short-current.json"
      },
      {
        "filename": "short-history.json",
        "label": "Historiska blankningspositioner JSON",
        "url": "short-history.json"
      },
      {
        "filename": "short-aggregate.json",
        "label": "Aggregerad blankning JSON",
        "url": "short-aggregate.json"
      },
      {
        "filename": "manifest.json",
        "label": "Hämtningsmanifest JSON",
        "url": "manifest.json"
      }
    ]
  },
  "llms_url": "/company/episurf-medical-ab/llms.txt",
  "json_url": "/company/episurf-medical-ab/company.json",
  "document_index_url": "/company/episurf-medical-ab/documents.json",
  "absolute_url": "https://spela.port0.org/company/episurf-medical-ab"
}